Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to evaluate the potential supportive effects of rice bran arabinoxylan compound (Biobran) in patients with breast cancer receiving paclitaxel and doxorubicin chemotherapy. The study will assess chemotherapy-related side effects, quality of life, tumor size, tumor antigens, and routine blood test parameters over 24 weeks of treatment.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 65
Healthy Volunteers: f
View:
• Breast cancer stage I-III
Locations
Other Locations
Taiwan
China Medical University
NOT_YET_RECRUITING
Taichung
China Medical University Hospital
RECRUITING
Taichung
Contact Information
Primary
Chong-Kuei Lii, PhD
cklii@mail.cmu.edu.tw
+886916226551
Backup
Yi-Chen Huang, PhD
yichenhuang@mail.cmu.edu.tw
886915754860
Time Frame
Start Date: 2025-04-07
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 96
Treatments
No_intervention: Placebo
3 g placebo per day for 24 weeks
Experimental: Biobran
3 g Biobran per day for 24 weeks
Related Therapeutic Areas
Sponsors
Leads: China Medical University Hospital